BeStock  
Stocks › Medical Devices › LMRI

Lumexa Imaging LMRI

US equityMarket cap rank #3228Medical Devices
$10.59 −$0.12 (-1.12%)
Pre-market · Oct 8, 8:20 am ET · After hours $10.59 0.00%
Open$10.57
Prev close$10.71
Day range$10.49 – $10.71
Volume164.0K
Market cap$1.02B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±19.1%last 3 reports
Closed higher1 of 333% of the time
Best reaction+4.0%
Worst reaction-29.8%

Stock move on the day after each report

-29.8%2025/Q4-23.3%2026/Q1+4.0%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q212 Aug 2026After Market–+4.01%–
2026/Q112 May 2026After Market–-23.33%–
2025/Q426 Mar 2026Pre Market–-29.84%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Outpatient$196.21M 73.1%
  • Professional$72.25M 26.9%

Latest reported quarter: Q2, ended Jun 2026

Revenue$264.16M+5.1% YoY
Operating profit$4.40M-60.6% YoY
Net profit$2.75M+138.0% YoY
Diluted EPS$0.03+139.3% YoY
Free cash flow$22.53M+991.2% YoY
Operating cash flow$32.80M

Revenue, last 7 quarters

$248.0MDec '24$245.0MMar '25$251.4MJun '25$258.9MSep '25$267.7MDec '25$252.5MMar '26$264.2MJun '26

Net profit, last 7 quarters

$-25.1MDec '24$-7.7MMar '25$-7.2MJun '25$-3.5MSep '25$-28.7MDec '25$1.7MMar '26$2.7MJun '26

Profitability & balance sheet

Gross margin14.9%
Operating margin1.4%
Net margin-2.7%
Return on equity-4.5%
Return on assets-1.5%
Return on invested capital1.7%
Current ratio1.44
Liabilities / assets66.0%
Cash & investments$69.71M
Total debt$948.82M
Net cash (debt)-$879.12M
Free cash flow / sales3.0%

Discussion

No comments yet — be the first to weigh in on LMRI.

Leave a comment

Scroll to Top